Riskpilot← Back to searchSign inGet full accessPALLA PHARMA NORWAY AS
ASActiveOrg 918275452Gruveveien 1, 3770 KragerøManufacture of pharmaceutical preparations · NACE 2120Est. 201666 employees
Revenue 2024
NOK 213,2M
+28% vs 2023
EBITDA margin
10.5%
+109% vs 2023
Equity ratio
31.3%
Financial strength
Net profit 2024
NOK 13,4M
+194% vs 2023
| Revenue | NOK 213,2M | +28% |
| EBITDA | NOK 22,3M | +109% |
| Net profit | NOK 13,4M | +194% |
| Total assets | NOK 168,1M | +38% |
| Equity | NOK 52,6M | +34% |
| Employees | 66 | — |
Legal name
PALLA PHARMA NORWAY AS
Org number
918275452
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
20. desember 2016
Share capital
NOK 3 600 000
Employees
66 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Å drive virksomhet innenfor produksjon av farmasøytiske produkter.
Address
Gruveveien 1, 3770 Kragerø
Phone
+4735982000
Email
enquiries@pallapharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 117 995 | 97 211 | 83 926 | 166 539 | 213 177 |
| Staff expenses | −47 492 | −60 225 | −59 044 | −47 893 | −66 926 |
| EBITDA | −83 685 | −100 322 | −71 006 | 10 679 | 22 335 |
| Depreciation & amort. | −3 789 | −3 641 | −3 312 | −3 695 | −2 658 |
| EBIT | −87 474 | −103 962 | −74 318 | 6 984 | 19 677 |
| Net financials | −10 510 | −3 027 | −443 | −2 441 | −6 308 |
| Profit before tax | −97 984 | −106 989 | −74 761 | 4 542 | 13 369 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −97 984 | −106 989 | −74 761 | 4 542 | 13 369 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 119 127 | 98 665 | 88 038 | 121 582 | 168 106 |
| Equity | −80 397 | −187 386 | −1 902 | 39 240 | 52 609 |
| Long-term debt | 45 440 | 45 440 | 55 000 | 26 740 | 26 600 |
| Short-term debt | 154 084 | 240 611 | 34 940 | 55 603 | 88 897 |
| Total debt | 199 523 | 286 051 | 89 940 | 82 343 | 115 497 |
EBITDA margin
10.5%
This company
15.8%
Market median
-34% vs market
20202024
Equity ratio
31.3%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
25.4%
This company
18.4%
Market median
+38% vs market
20202024
Net profit margin
6.3%
This company
8.1%
Market median
-22% vs market
20202024
Asset turnover
1.27×
This company
1.12×
Market median
+13% vs market
20202024
Debt / equity
2.20×
This company
0.62×
Market median
-255% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
AH Deputy Member | Deputy Member | 2023 |
BK Chief Executive Officer | Chief Executive Officer | 2023 |
FA Deputy Member | Deputy Member | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (5) | ||
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2024 – 2025 | |
| Board of Directors | 2024 – 2025 | |
| Chairman | 2019 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Palla Pharma Norway Holding As
PALLA PHARMA NORWAY AS Board members of PALLA PHARMA NORWAY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anita Hillingsæther Blankenberg | Deputy Member | 0 companies |
| Bernt Kåre Vildalen | Chief Executive Officer | 0 companies |
| Finn Asbjørn Sørensen | Deputy Member | 0 companies |
| Marianne Erlund | Board of Directors | 0 companies |
| Andrew Howatson | Board of Directors | 0 companies |
| Gro Anita Liane | Board of Directors | 0 companies |
| Jørn Henning Isaksen | Board of Directors | 0 companies |
| Preben René Hjallum | Board of Directors | 0 companies |
| Lars Markus Solheim | Board of Directors | 0 companies |
| Craig James Sweenie | Chairman | 0 companies |
| Morten Andresen | Chairman | 0 companies |